CYTK - Cytokinetics drops after public offering prices
2024-05-23 06:23:36 ET
More on Cytokinetics
- Cytokinetics, Incorporated (CYTK) Q1 2024 Earnings Call Transcript
- Cytokinetics, Incorporated: Buyout Speculation Persists
- Cytokinetics: CEO Talks Down Buyout Prospects
- Cytokinetics to get up to $575M in funding from Royalty Pharma
- Cytokinetics CEO Blum says positioned to market heart drug aficamten by itself